Akebia Therapeutics, Inc.’s AKBA share price has dipped by 28.17%, which has investors questioning if this is right time to ...

Having a low hemoglobin level or a high erythropoiesis-stimulating agent (ESA) resistance index (ERI) is associated with faster decline in residual kidney function in patients undergoing peritoneal ...

The European Medicines Agency’s (EMA’) human medicines committee (CHMP) has recommended two new medicines and three ...

Klaus Zellmer, CEO, says a decision will be made this year where the top priority is to have a partner with strong roots in ...

Medical tourism is the practice of travelling outside the country to seek medical treatment. The desire for high-quality ...

People with a complex heart, kidney and metabolic-related condition who got better quality sleep were less likely to have an advanced stage of the illness than those getting poor sleep, according to a ...

The rising prevalence of CKD and ESRD is one of the primary drivers ... Developed countries such as the United States, Germany, and Japan account for a substantial market share, but emerging ...

US President Trump appears to be following through on his threats to impose additional tariffs on all new vehicle imports to ...

Superbikes are the preferred ride of the elite but make up less than 1% of India’s motorcycle market. The govt has already ...

Roxadustat is approved in China, Europe, Japan, and numerous other countries for the treatment of anemia of CKD in adult patients on dialysis (DD) and not on dialysis (NDD). FibroGen has the sole ...

Berlin: Bayer has announced that the Company has received Priority Review designation from the U.S. Food and Drug ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...